Caricamento...
Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
Background and objectives: Following the discovery of new drugs, physicians and pharmaceutical companies have become interested in examining patients’ mortality and morbidity rates. In this respect, the effects of methotrexate (MTX)+etanercept/infliximab (ETA/INF) therapy on the survival of rheumato...
Salvato in:
| Pubblicato in: | Pragmat Obs Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503221/ https://ncbi.nlm.nih.gov/pubmed/31118865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/POR.S194408 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|